Literature DB >> 19241369

Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3.

Lei Jin1, Heidi Galonek, Kristine Israelian, Wendy Choy, Michael Morrison, Yu Xia, Xiaohong Wang, Yihua Xu, Yuecheng Yang, Jesse J Smith, Ethan Hoffmann, David P Carney, Robert B Perni, Michael R Jirousek, Jean E Bemis, Jill C Milne, David A Sinclair, Christoph H Westphal.   

Abstract

SIRT3 is a key mitochondrial protein deacetylase proposed to play key roles in regulating mitochondrial metabolism but there has been considerable debate about its actual size, the sequences required for activity, and its subcellular localization. A previously cloned mouse SIRT3 has high sequence similarity with the C-terminus of human SIRT3 but lacks an N-terminal mitochondrial targeting sequence and has no detectable deacetylation activity in vitro. Using 5' rapid amplification of cDNA ends, we cloned the entire sequence of mouse SIRT3, as well as rat and rabbit SIRT3. Importantly, we find that full-length SIRT3 protein localizes exclusively to the mitochondria, in contrast to reports of SIRT3 localization to the nucleus. We demonstrate that SIRT3 has no deacetylation activity in vitro unless the protein is truncated, consistent with human SIRT3. In addition, we determined the inhibition constants and mechanism of action for nicotinamide and a small molecule SIRT3 inhibitor against active mouse SIRT3 and show that the mechanisms are different for the two compounds with respect to peptide substrate and NAD(+). Thus, identification and characterization of the actual SIRT3 sequence should help resolve the debate about the nature of mouse SIRT3 and identify new mechanisms to modulate enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241369      PMCID: PMC2760358          DOI: 10.1002/pro.50

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  48 in total

1.  Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.

Authors:  J Landry; J T Slama; R Sternglanz
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

2.  Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Authors:  Sylvia C Dryden; Fatimah A Nahhas; James E Nowak; Anton-Scott Goustin; Michael A Tainsky
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

Authors:  Brian J North; Brett L Marshall; Margie T Borra; John M Denu; Eric Verdin
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

4.  Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.

Authors:  Emma Langley; Mark Pearson; Mario Faretta; Uta-Maria Bauer; Roy A Frye; Saverio Minucci; Pier Giuseppe Pelicci; Tony Kouzarides
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

5.  Cloning and characterization of two mouse genes with homology to the yeast Sir2 gene.

Authors:  Y H Yang; Y H Chen; C Y Zhang; M A Nimmakayalu; D C Ward; S Weissman
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

6.  Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.

Authors:  Kevin J Bitterman; Rozalyn M Anderson; Haim Y Cohen; Magda Latorre-Esteves; David A Sinclair
Journal:  J Biol Chem       Date:  2002-09-23       Impact factor: 5.157

7.  SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria.

Authors:  Patrick Onyango; Ivana Celic; J Michael McCaffery; Jef D Boeke; Andrew P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

8.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

9.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

10.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.

Authors:  Bjorn Schwer; Brian J North; Roy A Frye; Melanie Ott; Eric Verdin
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  71 in total

Review 1.  Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.

Authors:  Michael N Sack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

2.  Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms.

Authors:  Jianjun Bao; Zhongping Lu; Joshua J Joseph; Darin Carabenciov; Christopher C Dimond; Liyan Pang; Leigh Samsel; J Philip McCoy; Jaime Leclerc; Phuongmai Nguyen; David Gius; Michael N Sack
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

3.  trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Authors:  Jinrong Fu; Jing Jin; Robert H Cichewicz; Serena A Hageman; Trevor K Ellis; Lan Xiang; Qi Peng; Mali Jiang; Nicolas Arbez; Katelyn Hotaling; Christopher A Ross; Wenzhen Duan
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

4.  Sirtuin-3 (SIRT3) and the Hallmarks of Cancer.

Authors:  Turki Y Alhazzazi; Pachiyappan Kamarajan; Eric Verdin; Yvonne L Kapila
Journal:  Genes Cancer       Date:  2013-03

5.  Characterization of murine SIRT3 transcript variants and corresponding protein products.

Authors:  Yongjie Yang; Basil P Hubbard; David A Sinclair; Qiang Tong
Journal:  J Cell Biochem       Date:  2010-11-01       Impact factor: 4.429

6.  Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria.

Authors:  Huseyin Cimen; Min-Joon Han; Yongjie Yang; Qiang Tong; Hasan Koc; Emine C Koc
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 7.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

8.  Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle.

Authors:  Orsolya M Palacios; Juan J Carmona; Shaday Michan; Ke Yun Chen; Yasuko Manabe; Jack Lee Ward; Laurie J Goodyear; Qiang Tong
Journal:  Aging (Albany NY)       Date:  2009-08-15       Impact factor: 5.682

9.  SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator.

Authors:  Han Dai; Lauren Kustigian; David Carney; April Case; Thomas Considine; Basil P Hubbard; Robert B Perni; Thomas V Riera; Bruce Szczepankiewicz; George P Vlasuk; Ross L Stein
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

10.  Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis.

Authors:  Xingxing Kong; Rui Wang; Yuan Xue; Xiaojun Liu; Huabing Zhang; Yong Chen; Fude Fang; Yongsheng Chang
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.